82 FR 30877 - National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 126 (July 3, 2017)

Page Range		30877-30877
FR Document		2017-13896

Federal Register, Volume 82 Issue 126 (Monday, July 3, 2017)

[Federal Register Volume 82, Number 126 (Monday, July 3, 2017)]
[Notices]
[Page 30877]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-13896]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; Review of K24 
Application.
    Date: July 25, 2017.
    Time: 11:00 a.m. to 1:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Barbara A. Woynarowska, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 754, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 
402-7172, [email protected].

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; PAR-16-127: NIDDK 
Program Projects (P01).
    Date: August 7, 2017.
    Time: 1:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Ann A. Jerkins, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 7119, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, 301-
594-2242, [email protected].

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; Limited Competition: 
Data Coordinating Center for Type 1 Diabetes TrialNet (UC4).
    Date: August 15, 2017.
    Time: 1:00 p.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Paul A. Rushing, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 7345, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 
594-8895, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)

    Dated: June 27, 2017.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-13896 Filed 6-30-17; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 82, No. 126 / Monday, July 3, 2017 / Notices 30877

substance use disorder treatment, Dated: June 26, 2017. Special Emphasis Panel; Limited
employers, and patients or their John R. Graham, Competition: Data Coordinating Center for
advocates. Written comments may be Acting Assistant Secretary for Planning and Type 1 Diabetes TrialNet (UC4).
submitted to parity@hhs.gov for two Evaluation. Date: August 15, 2017.
weeks prior to the meeting through [FR Doc. 2017–13959 Filed 6–30–17; 8:45 am] Time: 1:00 p.m. to 2:00 p.m.
August 10, 2017. Agenda: To review and evaluate grant
BILLING CODE 4150–15–P
DATES: The meeting will be held on July applications.
27, 2017 from 9:30 a.m. to 11:30 a.m. Place: National Institutes of Health, Two
EDT. DEPARTMENT OF HEALTH AND Democracy Plaza, 6707 Democracy
HUMAN SERVICES Boulevard, Bethesda, MD 20892 (Telephone
ADDRESSES: The meeting will be held in Conference Call).
the first floor auditorium in the Hubert Contact Person: Paul A. Rushing, Ph.D.,
National Institutes of Health
H. Humphrey Building, 200 Scientific Review Officer, Review Branch,
Independence Avenue SW., National Institute of Diabetes and DEA, NIDDK, National Institutes of Health,
Washington, DC 20201. Digestive and Kidney Diseases; Notice Room 7345, 6707 Democracy Boulevard,
Comments: The time for oral of Closed Meetings Bethesda, MD 20892–5452, (301) 594–8895,
comments will be limited to five (5) rushingp@extra.niddk.nih.gov.
minutes per individual. In lieu of oral Pursuant to section 10(d) of the
(Catalogue of Federal Domestic Assistance
comments, formal written comments Federal Advisory Committee Act, as
Program Nos. 93.847, Diabetes,
may be submitted for the record to amended (5 U.S.C. App.), notice is
Endocrinology and Metabolic Research;
Laurel Fuller, ASPE, 200 Independence hereby given of the following meetings.
93.848, Digestive Diseases and Nutrition
Avenue SW., Room 424E, Washington, The meetings will be closed to the
Research; 93.849, Kidney Diseases, Urology
DC 20201; all comments should be public in accordance with the
and Hematology Research, National Institutes
submitted to parity@hhs.gov. Those provisions set forth in sections of Health, HHS)
submitting comments should identify 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
themselves and any relevant as amended. The grant applications and Dated: June 27, 2017.
organizational affiliations. the discussions could disclose David Clary,
FOR FURTHER INFORMATION CONTACT: confidential trade secrets or commercial Program Analyst, Office of Federal Advisory
Laurel Fuller (202) 690–5949, property such as patentable material, Committee Policy.
Laurel.Fuller@hhs.gov. and personal information concerning [FR Doc. 2017–13896 Filed 6–30–17; 8:45 am]
SUPPLEMENTARY INFORMATION: individuals associated with the grant BILLING CODE 4140–01–P
Procedure and Agenda: This meeting applications, the disclosure of which
is open to the public. Please allow 45 would constitute a clearly unwarranted
minutes to go through security and walk invasion of personal privacy. DEPARTMENT OF HEALTH AND
to the meeting room. The meeting will Name of Committee: National Institute of HUMAN SERVICES
also be webcast at www.hhs.gov/live. Diabetes and Digestive and Kidney Diseases
Note: Seating will be limited to 75 Special Emphasis Panel; Review of K24 National Institutes of Health
attendees; this listening session will Application.
also be webcast online at www.hhs.gov/ Date: July 25, 2017. National Cancer Institute; Amended
live. Those wishing to attend the Time: 11:00 a.m. to 1:00 p.m. Notice of Meeting
meeting must send an email to parity@ Agenda: To review and evaluate grant
hhs.gov and put ‘‘July 27 Public applications.
Place: National Institutes of Health, Two
Notice is hereby given of a change in
Meeting’’ in the Subject line by Friday, the meeting of the National Cancer
Democracy Plaza, 6707 Democracy
July 21, 2017 so that their names may Boulevard, Bethesda, MD 20892 (Telephone Institute Special Emphasis Panel, July
be put on a list of expected attendees Conference Call). 12, 2017, 11:00 a.m. to July 12, 2017,
and forwarded to the security officers Contact Person: Barbara A. Woynarowska, 3:00 p.m., National Cancer Institute
the Humphrey Building. In the email Ph.D., Scientific Review Officer, Review Shady Grove, Shady Grove, 9609
please also indicate which group you Branch, DEA, NIDDK, National Institutes of
Medical Center Drive, 7W114,
are representing (State health Health, Room 754, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452, (301) Rockville, MD 20850 which was
commissioners, State agencies, State
attorneys general, the National 402–7172, woynarowskab@niddk.nih.gov. published in the Federal Register on
Association of Insurance Name of Committee: National Institute of May 31, 2017, 82 FR 24983.
Commissioners, health insurance Diabetes and Digestive and Kidney Diseases The meeting notice is amended to
issuers, providers of mental health and Special Emphasis Panel; PAR–16–127: change the meeting title to
substance use disorder treatment, NIDDK Program Projects (P01).
‘‘Biospecimen and Innovative
Date: August 7, 2017.
employers, and patients or their Time: 1:00 p.m. to 5:00 p.m. Technology’’. The meeting is closed to
advocates; or other). Any interested Agenda: To review and evaluate grant the public.
member of the public who is a non-U.S. applications. Dated: June 27, 2017.
citizen should include this information Place: National Institutes of Health, Two
at the time of registration to ensure that Democracy Plaza, 6707 Democracy Melanie J. Pantoja,
the appropriate security procedure to Boulevard, Bethesda, MD 20892 (Telephone Program Analyst, Office of Federal Advisory
gain entry to the building is carried out. Conference Call). Committee Policy.
sradovich on DSK3GMQ082PROD with NOTICES

Although the meeting is open to the Contact Person: Ann A. Jerkins, Ph.D., [FR Doc. 2017–13895 Filed 6–30–17; 8:45 am]
public, procedures governing security Scientific Review Officer, Review Branch,
BILLING CODE 4140–01–P
DEA, NIDDK, National Institutes of Health,
and the entrance to federal buildings
Room 7119, 6707 Democracy Boulevard,
may change without notice. If you wish Bethesda, MD 20892–5452, 301–594–2242,
to make a public comment, you must jerkinsa@niddk.nih.gov.
note that within your email. Name of Committee: National Institute of
Authority: 114–255 Pub. L. 114–255. Diabetes and Digestive and Kidney Diseases

VerDate Sep<11>2014 17:53 Jun 30, 2017 Jkt 241001 PO 00000 Frm 00062 Fmt 4703 Sfmt 9990 E:\FR\FM\03JYN1.SGM 03JYN1

Document Created: 2018-11-14 10:19:01
Document Modified: 2018-11-14 10:19:01

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		July 25, 2017.
FR Citation		82 FR 30877

82 FR 30877 - National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 82, Issue 126 (July 3, 2017)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health